Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RNA, 5S ribosomal pseudogene 33 (RNA5SP33) is a processed, non-functional pseudogene in the human genome, originally derived from duplication of the 5S ribosomal RNA gene. Unlike the canonical 5S rRNA gene, which encodes a structural RNA essential for ribosome function and translation, RNA5SP33 does not produce a functional RNA or protein. While some 5S rRNA pseudogenes can be transcribed and may participate in regulatory functions (like acting as competing endogenous RNAs), there is no evidence that RNA5SP33 is itself translated, expressed, or implicated in disease or therapeutic pathways. Thus, it is not considered a therapeutic target. RNA5SP33 is a pseudogene, not an active target or receptor. There is no known therapeutic, biomarker, or safety relevance for RNA5SP33. If the query intended a functional ribosomal target, reference should be made to 5S ribosomal RNA (5S rRNA) and not to a pseudogene like RNA5SP33.
None—no interacting drugs or therapeutic targeting described.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RNA, 5S ribosomal pseudogene 33 (RNA5SP33).